Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2025 USD ($) segment	Dec. 31, 2024 USD ($)
Product Information [Line Items]
Number of operating segments | segment	1
Impairment to goodwill	$ 0	$ 0
Impairment		0
Loss on impairment of investment	2,000,000	0
Cyrus Biotechnology, Inc.
Product Information [Line Items]
Loss on impairment of investment	2,000,000.0	$ 0
In Process Research and Development
Product Information [Line Items]
Impairment	$ 56,700,000
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]	Impairment of indefinite-lived intangible and long-lived assets
Minimum
Product Information [Line Items]
Lease term	2 years
Lease renewal term	1 year
Maximum
Product Information [Line Items]
Lease term	8 years
Lease renewal term	5 years
Furniture and fixtures
Product Information [Line Items]
Estimated useful life	7 years
Laboratory Equipment, Software and Office Equipment
Product Information [Line Items]
Estimated useful life	5 years
Computer equipment and software
Product Information [Line Items]
Estimated useful life	3 years